Huntington’s disease biomarkers appear 24 years before clinical symptomsJune 5, 2020Rare DiseasesNeuromuscular DisordersMovement Disorders
Dermatomyositis without dermatitis correlates with autoantibodiesApril 24, 2020Neuromuscular Disorders
First case of COVID-19 presenting as Guillain-Barré reportedApril 9, 2020COVID-19 UpdatesRare DiseasesNeuromuscular Disorders
As costs for neurologic drugs rise, adherence to therapy dropsFebruary 21, 2020Mixed TopicsAlzheimer's & CognitionMovement DisordersParkinson's DiseaseMultiple SclerosisEpilepsy & SeizuresNeuromuscular Disorders
FDA approves Vyondys 53 for Duchenne muscular dystrophy subtypeDecember 17, 2019Neuromuscular DisordersPediatrics
Benefits of focused ultrasound thalamotomy for essential tremor persist for 3 yearsNovember 21, 2019Neuromuscular Disorders
AVXS-101 may result in long-term motor improvements in SMANovember 18, 2019Rare DiseasesPediatricsNeuromuscular Disorders
Don’t miss neuromuscular complications of cancer immunotherapyNovember 14, 2019Neuromuscular Disorders
Ataluren shows real-world benefit for nonsense mutation Duchenne muscular dystrophyNovember 7, 2019Neuromuscular DisordersRare Diseases
AChR autoantibody subtype testing may improve accuracy of myasthenia gravis evaluationsOctober 29, 2019Neuromuscular Disorders
Thromboembolic events more likely among CIDP patients with CVADOctober 29, 2019Neuromuscular Disorders
CMT1A neuropathy improves with investigational drug PXT3003October 29, 2019Neuromuscular DisordersRare Diseases
Edasalonexent may slow progression of Duchenne muscular dystrophyOctober 28, 2019Neuromuscular DisordersPediatrics
Primary periodic paralysis attacks reduced with long-term dichlorphenamideOctober 19, 2019Neuromuscular Disorders
